|
a b c d e f g h i j k l m n o p q r s t u v w y z search |
TeachMeFinance.com - explain yttrium Y 90 ibritumomab tiuxetan yttrium Y 90 ibritumomab tiuxetan --
An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody.
|